Growth hormone (GH) is frequently the first hormone to be affected in hypothalamic-pituitary disorders, however deficiency can remain unrecognized by other specialists, which could lead to delays in referral for treatment. This evidence concerns the gene GH1 and hyperinsulinemic hypoglycemia, familial, 4.